Gene-drug interactions (data source: DGIdb)
Gene Name Entrez ID Drug Name Chembl ID Interaction Types Sources publications
CRHR2 1395 SAUVAGINE CHEMBL439883 agonist GuideToPharmacologyInteractions
CRHR2 1395 WORTMANNIN CHEMBL428496 agonist, antagonist TdgClinicalTrial, GuideToPharmacologyInteractions, TTD
CRHR2 1395 CHEMBL1236539 CHEMBL1236539 agonist GuideToPharmacologyInteractions
CRHR2 1395 NAPHTHALENE CHEMBL16293 antagonist GuideToPharmacologyInteractions
CRHR2 1395 ENTINOSTAT CHEMBL27759 antagonist TTD

Variant-drug associations (data source: PharmGKB)
Gene Name Variant Alleles Chemical Phenotype Category Significance Notes Sentence Publications Annotation ID
CRHR2 rs73294475 CT salbutamol efficacy yes The allele associated with increased response and low frequency is not explicitly stated. Response is increased for carriers of the rare, minor allele. GALAII genotyping was done using the Affymetrix LAT1 Array, which was designed to capture Latino population variation. This was assessed as a replication attempt for a previously reported association of a different CRHR2 SNP with response to bronchodilators. Bonferroni correction was performed according to the number of SNPs included that are within 50 kb up and downstream of CRHR2. Genotype CT is associated with increased response to salbutamol in children with Asthma as compared to genotype TT. 23992748 1183680162
CRHR2 rs2284220 G salbutamol efficacy yes Allele G is associated with decreased response to salbutamol in people with Asthma as compared to allele A. 18408560 699639185
CRHR2 rs7793837 T salbutamol efficacy no Allele T is not associated with decreased response to salbutamol and selective beta-2-adrenoreceptor agonists in people with Asthma as compared to allele A. 18408560 1448634968
CRHR2 rs2267715 G salbutamol efficacy yes Allele G is associated with decreased response to salbutamol in people with Asthma as compared to allele A. 18408560 699639154
CRHR2 rs2267715 G salbutamol efficacy no Allele G is not associated with decreased response to salbutamol in people with Asthma as compared to allele A. 18408560 699639165
CRHR2 rs2284220 G salbutamol efficacy no Allele G is not associated with decreased response to salbutamol in people with Asthma as compared to allele A. 18408560 699639192
CRHR2 rs255100 A salbutamol efficacy yes The A allele of this variant is associated with reduced bronchodilator response in CAMP cohort. However, this association is not significant in the other two cohorts tested. Allele A is associated with decreased response to salbutamol in people with Asthma as compared to allele T. 18408560 699639201
CRHR2 rs7793837 T salbutamol efficacy yes Allele T is associated with decreased response to salbutamol and selective beta-2-adrenoreceptor agonists in people with Asthma as compared to allele A. 18408560 655386940
CRHR2 rs7793837 T salbutamol efficacy yes Allele T is associated with decreased response to salbutamol and selective beta-2-adrenoreceptor agonists in people with Asthma as compared to allele A. 18408560 655386935
CRHR2 rs255100 A salbutamol efficacy no in replication cohort with adult patients. Allele A is not associated with decreased response to salbutamol in people with Asthma as compared to allele T. 18408560 699639212
CRHR2 rs2270007 CC + CG citalopram efficacy yes This association is for response at week 4 but not at week 12. The allele associated with worse response is described as G. This is a G/C SNP, so this is ambiguous. The gene is on the negative chromosomal strand, so I am guessing that the authors meant negative chromosomal strand G (= positive chromosomal strand C). The OR entered is for increased risk of non-response. Authors note that Bonferroni correction was not done and that they think that it would be overly conservative to do so. p entered is not corrected; 7 SNPs were tested. Number of "cases" and "controls" entered are responders and non-responders. Genotypes CC + CG are associated with decreased response to citalopram in people with Depressive Disorder, Major as compared to genotype GG. 17467808 982015348
CRHR2 rs255100 A salbutamol efficacy no Allele A is not associated with decreased response to salbutamol in people with Asthma as compared to allele T. 18408560 1448634923
CRHR2 rs2284220 G salbutamol efficacy no Allele G is not associated with decreased response to salbutamol in people with Asthma as compared to allele A. 18408560 1448634953